Hydrochlorothiazide [clinicaltrials_resource:f678b008f2450ca29bc4ebc04dca972c]
Diuretics, Hypertension, and Arrhythmias Clinical Trial [clinicaltrials:NCT00000525]clinicaltrials:NCT00000620clinicaltrials:NCT00005520Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients With Essential Hypertension (Banyu Study)(0954A-302) [clinicaltrials:NCT00092209]clinicaltrials:NCT00110422A Randomized, Double-blind, Parallel-group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison With Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients With Mild to Moderate Hypertension [clinicaltrials:NCT00133185]INVEST: INternational VErapamil SR Trandolapril STudy [clinicaltrials:NCT00133692]Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension [clinicaltrials:NCT00139698]Combination of Telmisartan 40 mg Plus Hydrochlorothiazide (HCTZ) 12.5 mg vs. Telmisartan 40 mg Alone in Patients With Essential Hypertension Who Fail to Respond Adequately to Telmisartan Monotherapy [clinicaltrials:NCT00144222]Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 12.5 mg to Telmisartan 80 mg in Patients Failed in Telmisartan 80 mg [clinicaltrials:NCT00146341]3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension [clinicaltrials:NCT00153049]Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study (0954A-314) [clinicaltrials:NCT00157963]Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Comparing Telmisartan vs Valsartan. Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension [clinicaltrials:NCT00168779]A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome [clinicaltrials:NCT00170937]clinicaltrials:NCT00170950Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone [clinicaltrials:NCT00170989]VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil [clinicaltrials:NCT00171015]clinicaltrials:NCT00171054VALENCE: Valsartan Versus Atenolol on Exercise Capacity in Hypertensive Overweight Postmenopausal Women [clinicaltrials:NCT00171132]A Clinical Study to Evaluate the Long-term Safety (12 Months) of the Combination of Aliskiren 300 mg and Hydrochlorothiazide 25 mg [clinicaltrials:NCT00171405]Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria. [clinicaltrials:NCT00171561]Hypertension and Cardiovascular Risk Factors [clinicaltrials:NCT00171782]An Examination of the Safety and Blood Pressure Lowering Effect of Increasing Doses of Benicar® and Benicar® HCT in Patients With Hypertension [clinicaltrials:NCT00185068]Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker [clinicaltrials:NCT00185120]Olmesartan in Essential Hypertension [clinicaltrials:NCT00185172]Olmesartan Medoxomil in Atherosclerosis [clinicaltrials:NCT00185185]Aldosterone and Vascular Disease in Diabetes Mellitus [clinicaltrials:NCT00214825]Clinical Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Hydrochlorothiazide in Patients With Essential Hypertension. [clinicaltrials:NCT00219024]Long Term Safety of Aliskiren Alone or With the Optional Addition of Hydrochlorothiazide in Patients With Essential Hypertension [clinicaltrials:NCT00219037]A Clinical Study to Compare an Aliskiren Based Hypertensive Regimen With a Ramipril Based One Followed by a Randomized Withdrawal. [clinicaltrials:NCT00219063]A Clinical Study to Evaluate Safety & Efficacy of the Combination of Aliskiren, Valsartan & Hydrochlorothiazide in Diabetic Hypertensive Nonresponder Patients [clinicaltrials:NCT00219102]Olmesartan as an Add-on to Amlodipine in Hypertension [clinicaltrials:NCT00220233]clinicaltrials:NCT00223717PHARES Study: Management of Resistant Hypertension [clinicaltrials:NCT00224549]Pharmacodynamic Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Hypertensive Patients. [clinicaltrials:NCT00232882]Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR) [clinicaltrials:NCT00234858]SMOOTH - Blood Pressure Control in Diabetic/Obese Patients [clinicaltrials:NCT00239538]A Randomized, Double-blind, Placebo Controlled Comparison of Telmisartan Hydrochlorothiazide (HCT) and Valsartan HCT in Hypertension (HTN) Stage I/II Patients [clinicaltrials:NCT00240448]A Comparison of Telmisartan + Hydrochlorothiazide With Amlodipine + Hydrochlorothiazide in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension (ATHOS Study) [clinicaltrials:NCT00240474]A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension [clinicaltrials:NCT00241007]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Hydrochlorothiazide [clinicaltrials_resource:f678b008f2450ca29bc4ebc04dca972c]
Bio2RDF identifier
f678b008f2450ca29bc4ebc04dca972c
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:f678b008f2450ca29bc4ebc04dca972c
identifier
clinicaltrials_resource:f678b008f2450ca29bc4ebc04dca972c
title
Hydrochlorothiazide
@en
type
label
Hydrochlorothiazide [clinicaltrials_resource:f678b008f2450ca29bc4ebc04dca972c]
@en